These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6804389)
1. Side effects of immunization with liver attenuated Trypanosoma cruzi in mice and rabbits. Basombrío MA; Besuschio S; Cossio PM Infect Immun; 1982 Apr; 36(1):342-50. PubMed ID: 6804389 [TBL] [Abstract][Full Text] [Related]
2. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice. Basombrío MA; Segura MA; Nasser JR J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102 [TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi culture used as vaccine to prevent chronic Chagas' disease in mice. Basombrío MA; Besuschio S Infect Immun; 1982 Apr; 36(1):351-6. PubMed ID: 6804390 [TBL] [Abstract][Full Text] [Related]
4. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi]. Basombrio MA; Mora MC; Segura MA Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641 [TBL] [Abstract][Full Text] [Related]
5. Chagas' disease: a clinical, parasitological, immunological, and pathological study in rabbits. Teixeira AR; Figueiredo F; Rezende Filho J; Macêdo V Am J Trop Med Hyg; 1983 Mar; 32(2):258-72. PubMed ID: 6404186 [TBL] [Abstract][Full Text] [Related]
6. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites. Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: immunoprotection against metacyclic trypomastigotes obtained by immunization of mice with an affinity-purified antigen. Ruiz AM; Esteva M; Subias E; Moreno M; Rosenstein de Campanini A; Velazquez E; Segura EL Mol Biochem Parasitol; 1990 Feb; 39(1):117-25. PubMed ID: 2106075 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. Chuenkova M; Pereira ME J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of an attenuated Trypanosoma cruzi strain in rats. Analysis of survival, parasitemia and tissue damage. Revelli S; Basombrío MA; Valenti JL; Moreno H; Poli H; Morini JC Medicina (B Aires); 1993; 53(1):39-43. PubMed ID: 8246729 [TBL] [Abstract][Full Text] [Related]
10. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Basso B; Moretti ER; Vottero-Cima E Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328 [TBL] [Abstract][Full Text] [Related]
12. Prevention of electrocardiographic and histopathologic alterations in the murine model of Chagas' disease by preinoculation of an attenuated Trypanosoma cruzi strain. Cuneo CA; Molina de Raspi E; Basombrio MA Rev Inst Med Trop Sao Paulo; 1989; 31(4):248-55. PubMed ID: 2516641 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi. Ruiz AM; Esteva M; Cabeza Meckert P; Laguens RP; Segura EL Acta Trop; 1985 Dec; 42(4):299-309. PubMed ID: 2868632 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi. Chao D; Dusanic DG Am J Trop Med Hyg; 1985 Jul; 34(4):694-701. PubMed ID: 3927760 [TBL] [Abstract][Full Text] [Related]
15. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi. Zago MP; Barrio AB; Cardozo RM; Duffy T; Schijman AG; Basombrío MA Infect Immun; 2008 Jan; 76(1):443-51. PubMed ID: 17938222 [TBL] [Abstract][Full Text] [Related]
16. Immunization against experimental Chagas' disease by using culture forms of Trypanosoma cruzi killed with a solution of sodium perchlorate. Kierszenbaum F; Budzko DB Infect Immun; 1975 Sep; 12(3):461-5. PubMed ID: 170200 [TBL] [Abstract][Full Text] [Related]
17. A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease. Zwirner NW; Malchiodi EL; Chiaramonte MG; Fossati CA Infect Immun; 1994 Jun; 62(6):2483-9. PubMed ID: 7514576 [TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
19. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man. Teixeira AR; Teixeira ML; Santos-Buch CA Am J Pathol; 1975 Jul; 80(1):163-80. PubMed ID: 808136 [TBL] [Abstract][Full Text] [Related]
20. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Araujo FG; Morein B Infect Immun; 1991 Sep; 59(9):2909-14. PubMed ID: 1908826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]